CRISP3 and posterior cortical atrophy: The median expression of CRISP3 in metastatic PCa patients was 31.90 (27.73–41.65) ng/mL, while the median level of CRISP3 in non-metastatic patients was 22.75 (16.63–33.45) ng/mL.